Home > Insider Trading > Vertex Pharmaceuticals Inc / Ma > Profile

Vertex Pharmaceuticals Inc / Ma (VRTX)

Sector: Pharmaceutical Preparations

Related Insiders

Amit Sachdev, Evp, Chief Patient Officer, 2021-04-29
I Bruce Sachs, Director, 2021-04-16
Diana Mckenzie, Director, 2021-04-16

Amit Sachdev, Evp, Chief Patient Officer, 2021-04-29
I Bruce Sachs, Director, 2021-04-16
Diana Mckenzie, Director, 2021-04-16
Bastiano Sanna, Evp, Cell & Genetic Therapies, 2021-04-07
Joy Liu, Svp, General Counsel, 2021-03-08
M Paul Silva, Svp & Chief Accounting Officer, 2021-03-02
Jr F Charles Wagner, Evp & Chief Financial Officer, 2021-02-26
Ourania Tatsis, Evp, Chief Reg. & Quality Off., 2021-02-26
Michael Parini, Evp, Chief Adm, Leg & Bd Off, 2021-02-26
Reshma Kewalramani, Ceo & President, 2021-02-26
Carmen Bozic, Evp And Cmo, 2021-02-26
A Stuart Arbuckle, Evp, Chief Commercial Officer, 2021-02-26
David Altshuler, Evp, Global Research And Cso, 2021-02-26
M Jeffrey Leiden, Executive Chairman, 2021-02-19
N. Sangeeta Bhatia, Director, 2020-10-07
G Margaret Mcglynn, Director, 2020-08-26
D William Young, Director, 2020-06-03
Yuchun Lee, Director, 2020-06-03
C Terrence Kearney, Director, 2020-06-03
M Alan Garber, Director, 2020-06-03
Lloyd Carney, Director, 2020-06-03
Elaine Ullian, Director, 2019-06-04
Thomas Graney, Chief Financial Officer, 2018-10-02
F Ian Smith, Evp, Coo, 2018-07-03
Jeffrey Chodakewitz, Evp, 2018-04-02
S Joshua Boger, Director, 2017-06-09
Joseph Wayne Riley, Director, 2015-06-03
Thomas Connolly, Svp, Human Resources, 2014-12-16
L Kenneth Horton, Evp & Chief Legal Officer, 2014-11-19
E Megan Pace, Svp, Corp. Communications, 2014-11-19
Peter Mueller, Evp, Global R&d, Cso, 2014-06-18
Christiana Stamoulis, Svp, Corp Strategy & Bus Devlp, 2013-08-01
Lisa Kelly, Svp, Human Resources, 2013-02-07
Matthew Emmens, Director, 2012-11-20
Nancy Wysenski, Evp, Chief Commercial Officer, 2012-06-01
L Dennis Winger, Director, 2012-03-12
T David Howton, Svp & Chief Legal Officer, 2012-02-06
S Kenneth Boger, Svp & Chief Legal Officer, 2011-09-14
Eugene Cordes, Director, 2011-03-18
J Stuart Collinson, Director, 2010-06-02
A Charles Sanders, Director, 2010-06-02
W Roger Brimblecombe, Director, 2010-03-16
Kurt Graves, Officer, 2009-10-21
C Richard Garrison, Officer, 2009-05-19
C Freda Lewis-Hall, Officer, 2009-03-20
Eric Brandt, Director, 2009-01-30

Show All Insiders (46)

Hedge Fund Holdings

Filing Period:

Last updated on May 07, 2021, 12:00 am based on SEC 13F filings Last update: May 07, 2021, 12:00 am

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	ZWEIG DIMENNA PARTNERS Joe Dimenna	54,100	$11,626		0.8%
2.	HealthInvest Partners AB Anders Hallberg And Carl Bennet	35,000	$7,521		5.99%
3.	Fisher Asset Management Ken Fisher	26,053	$5,599	+5%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Sachs	$218.79	3,905	Director	26,210	2020-11-10	Filing
Sachs	$217.49	4,270	Director	22,305	2020-11-10	Filing
Sachs	$216.47	6,825	Director	18,035	2020-11-10	Filing
Mcglynn	$51.23	15	Director	1,088	2012-08-10	Filing
Mcglynn	$29.19	9	Director	1,088	2011-12-07	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Sachdev	$217.69	200	Officer	40,133	2021-04-27	Filing
Sachdev	$216.67	1,338	Officer	40,333	2021-04-27	Filing
Sachdev	$215.58	2,346	Officer	41,671	2021-04-27	Filing
Sanna	$214.99	389	Officer	35,834	2021-04-05	Filing
Sanna	$213.89	1,297	Officer	36,223	2021-04-05	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Bnp Paribas Arbitrage, Sa	340,339	$73,135,448	0.12%
2.	Exane Asset Management	155,252	$33,362,102	12.83%
3.	Bnp Paribas Arbitrage, SaPUT	1,030	$22,133,670	0.03%
4.	Dnb Asset Management As	73,779	$15,854,369	0.11%
5.	Bnp Paribas Arbitrage, SaCALL	375	$8,058,375	0.01%

News See All

Click here to See All News